Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ryoichi Takayanagi

Showing results (31-40 of 304) with videos related to

Pageof 31
Sort By:
Nihon Rinsho. Japanese Journal of Clinical Medicine|November 11, 2005
[Development of BMP-related drugs]Hisaya Kawate, Keizo Ohnaka, Ryoichi Takayanagi
Internal Medicine (Tokyo, Japan)|September 9, 2010
The new concept of therapeutic strategy for neuroendocrine tumors: important information from a case report of gastrinomaHisato Igarashi, Tetsuhide Ito, Ryoichi Takayanagi
Nihon Naika Gakkai Zasshi. the Journal of the Japanese Society of Internal Medicine|June 27, 2012
[Endocrine disease:progress in diagnosis and treatment topics: I. Progress in diagnosis: 3. The handling of adrenal disease and problems, 1) adrenal incidentaloma and subclinical Cushing's syndrome]Ryoichi Takayanagi, Hisaya Kawate, Toshihiko Yanase
Clinical Calcium|March 19, 2005
[Pathogenesis and treatment of glucocorticoid-induced osteoporosis]Ryoichi Takayanagi, Keizo Ohnaka, Hisaya Kawate
Nihon Naika Gakkai Zasshi. the Journal of the Japanese Society of Internal Medicine|March 26, 2003
[Cofactor diseases]Toshihiko Yanase, Masahiro Adachi, Ryoichi Takayanagi, et al.
Rinsho Byori. the Japanese Journal of Clinical Pathology|February 7, 2013
[Disease management for diabetes mellitus to prevent the onset and progression of complications]Kunihisa Kobayashi, Naoki Nakashima, Toyoshi Inoguchi, et al.
Scandinavian Journal of Gastroenterology|December 17, 2009
High-density lipoprotein cholesterol improves the model for end-stage liver disease scoring system for prognostic prediction of acute liver failureMasayuki Miyazaki, Masaki Kato, Masatake Tanaka, et al.
Immunotherapy|December 18, 2013
Targeting obesity, insulin resistance and Type 2 diabetes with immunotherapy: the challenges aheadMasakazu Fujii, Noriyuki Sonoda, Ryoichi Takayanagi, et al.
Clinical Interventions in Aging|October 9, 2013
Eldecalcitol for the treatment of osteoporosisYuko Noguchi, Hisaya Kawate, Masatoshi Nomura, et al.
Clinical Journal of Gastroenterology|July 21, 2015
The current managements of pancreatic diabetes in JapanKen Kawabe, Tetsuhide Ito, Hisato Igarashi, et al.
Pageof 31

Showing results (31-40 of 304) with videos related to

Sort By:
Pageof 31
Nihon Rinsho. Japanese Journal of Clinical Medicine|November 11, 2005
[Development of BMP-related drugs]Hisaya Kawate, Keizo Ohnaka, Ryoichi Takayanagi
Internal Medicine (Tokyo, Japan)|September 9, 2010
The new concept of therapeutic strategy for neuroendocrine tumors: important information from a case report of gastrinomaHisato Igarashi, Tetsuhide Ito, Ryoichi Takayanagi
Nihon Naika Gakkai Zasshi. the Journal of the Japanese Society of Internal Medicine|June 27, 2012
[Endocrine disease:progress in diagnosis and treatment topics: I. Progress in diagnosis: 3. The handling of adrenal disease and problems, 1) adrenal incidentaloma and subclinical Cushing's syndrome]Ryoichi Takayanagi, Hisaya Kawate, Toshihiko Yanase
Clinical Calcium|March 19, 2005
[Pathogenesis and treatment of glucocorticoid-induced osteoporosis]Ryoichi Takayanagi, Keizo Ohnaka, Hisaya Kawate
Nihon Naika Gakkai Zasshi. the Journal of the Japanese Society of Internal Medicine|March 26, 2003
[Cofactor diseases]Toshihiko Yanase, Masahiro Adachi, Ryoichi Takayanagi, et al.
Rinsho Byori. the Japanese Journal of Clinical Pathology|February 7, 2013
[Disease management for diabetes mellitus to prevent the onset and progression of complications]Kunihisa Kobayashi, Naoki Nakashima, Toyoshi Inoguchi, et al.
Scandinavian Journal of Gastroenterology|December 17, 2009
High-density lipoprotein cholesterol improves the model for end-stage liver disease scoring system for prognostic prediction of acute liver failureMasayuki Miyazaki, Masaki Kato, Masatake Tanaka, et al.
Immunotherapy|December 18, 2013
Targeting obesity, insulin resistance and Type 2 diabetes with immunotherapy: the challenges aheadMasakazu Fujii, Noriyuki Sonoda, Ryoichi Takayanagi, et al.
Clinical Interventions in Aging|October 9, 2013
Eldecalcitol for the treatment of osteoporosisYuko Noguchi, Hisaya Kawate, Masatoshi Nomura, et al.
Clinical Journal of Gastroenterology|July 21, 2015
The current managements of pancreatic diabetes in JapanKen Kawabe, Tetsuhide Ito, Hisato Igarashi, et al.
Pageof 31